• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 740-747.DOI: 10.3969/j.issn.1671-2587.2026.05.011

Previous Articles     Next Articles

Association of Direct Antiglobulin Test Patterns and Rh Phenotypes with Unexpected Antibody Identification Outcomes

XUE Jindan, LIU Jiayi, CUI Rui, CHEN Pengfei, GU Haihui   

  1. Department of Transfusion Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai 200433
  • Received:2026-09-02 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

Abstract: Objective To investigate the relationship of direct antiglobulin test (DAT) patterns and Rh phenotypes with undetermined specificity in antibody identification in patients with positive unexpected antibody screening results, thereby providing a basis for early recognition of specimens requiring complex antibody identification procedures. Methods Clinical data were retrospectively collected from 445 patients with positive unexpected antibody screening results at our hospital from January 2023 to June 2026. All patients underwent antibody identification, DAT, and Rh typing, and only the first eligible record was retained for each patient. DAT results were classified as negative, IgG-only, or C3d-containing. The primary outcome was undetermined specificity in antibody identification. Univariate and multivariable logistic regression analyses were performed, and clinical, clinical+Rh, and clinical+Rh+DAT models were developed. Results Among the 445 patients, antibody specificity could not be determined in 148 (33.3%). The rates of undetermined antibody specificity in patients with negative, IgG-only, and C3d-containing DAT results were 21.9% (63/288), 39.4% (28/71), and 66.3% (57/86), respectively (P<0.001). After adjustment for clinical disease category and Rh phenotype, the likelihood of undetermined antibody specificity remained higher in patients with IgG-only and C3d-containing DAT results than in DAT-negative patients, with adjusted odds ratios of 2.020 (95%CI: 1.106—3.686) and 6.440 (95%CI: 3.603—11.512), respectively. The CcDEe phenotype was also associated with the outcome (aOR=3.251, 95%CI: 1.909—5.537). Among 161 patients with Rh system antibodies, 148 (91.9%) showed phenotype-antibody concordance and 13 (8.1%) showed discordance; the DAT positivity rate was higher in the latter than in the former (61.5% vs 26.4%, P=0.021). The area under the receiver operating characteristic curve (AUROC) was 0.651, 0.703, and 0.770 for the three models, respectively, with P<0.001 for both adjacent-model comparisons. Conclusion Among patients with positive unexpected antibody screening results, both IgG-only and C3d-containing DAT results were independently associated with undetermined antibody specificity, with a stronger association for C3d-containing DAT results. After sequentially adding Rh phenotype and DAT results to the clinical data-based model, the model's ability to distinguish antibody specificity that was not clearly defined gradually improved, enabling early identification of specimens requiring complex identification and thereby improving the timeliness of clinical blood transfusion.

Key words: Direct antiglobulin test, Unexpected antibody, Rh phenotype, Antibody identification

CLC Number: